Delivery Order SPE2DB20D3103-SPE2DB22FM3H2
Award Date 1/18/22
Potential Completion Date 1/19/22
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,818.90, is for the delivery of Mitomycin 5 mg vials, a specialty cancer medication. The contract is a firm fixed-price, delivery order type with a completion date of May 30, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- This is a delivery order (Contract #SPE2DB20D1100 | SPE2DB24FD9D4) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 5 mg Mitomycin vials. The award is valued at $2,977.68 and has a firm-fixed price. The contract has an ultimate completion date of September 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this delivery order, which is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Mitomycin 40 mg vials, a specialty medication, with a ceiling value of $5,676.96 and a period of performance through January 9, 2025. The contract is a firm-fixed price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,250,777 units of Mitomycin 5 mg vials, a chemotherapy medication. The contract has a firm fixed price of $2,751.36 and a completion date of May 15, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,219.52, is for the delivery of Mitomycin 5 mg vials, a specialty pharmaceutical product. The contract has an ultimate completion date of November 20, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside requirement, indicating open competition....
- This federal contract award is for the delivery of Mitomycin 5 mg vials to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,818.90 and was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of April 11, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,042.58 Firm Fixed Price delivery order is for the supply of 4,568,142,696 units of Mitomycin 5 mg vials, with a performance period through May 6, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 40 mg vials of the chemotherapy drug Mitomycin. The $3,905.06 firm-fixed price contract has a completion date of June 15, 2022. Amerisourcebergen is a major pharmaceutical distributor that maintains significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation,...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a delivery order valued at $2,899.00 for the supply of Mitomycin 5 mg vials, with an ultimate completion date of February 2, 2026. This is a firm fixed-price, non-set-aside contract with performance to be executed in Conshohocken, Pennsylvania. The award represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at up to...
- The Defense Logistics Agency awarded a $1,854.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mitomycin 20 mg vials, with an ultimate completion date of December 17, 2025. This is an unset-aside, competitively awarded contract supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, serving as a primary...